Basit öğe kaydını göster

dc.contributor.authorBilgiç Eltan, Sevgi
dc.contributor.authorKarakurt, Tuba
dc.contributor.authorYüksel, Rozerin Göze
dc.contributor.authorYalakı, Aysun İlhan
dc.contributor.authorDurankuş, Ferit
dc.contributor.authorDut, Raziye
dc.contributor.authorAltun, Ekin Zeynep
dc.contributor.authorAygün, Burcu
dc.contributor.authorKaçar, Dilek
dc.contributor.authorŞenkal, Evrim
dc.contributor.authorArınç, Asena Pınar Sefer
dc.contributor.authorÖzen, Ahmet Oğuzhan
dc.contributor.authorKarakoç Aydıner, Elif
dc.contributor.authorCavkaytar, Özlem
dc.date.accessioned2025-08-05T11:32:22Z
dc.date.available2025-08-05T11:32:22Z
dc.date.issued2025en_US
dc.identifier.citationBilgic‐Eltan, S., Karakurt, T., Yuksel, R. G., Yalaki, A. I., Durankus, F., Dut, R., Altun, E. Z., Aygun, B., Kacar, D., Senkal, E., Sefer Arinc, A. P., Gurel, B. A., Baris, S., Arga, M., Ozen, A. O., Karakoc‐Aydiner, E., & Cavkaytar, O. (2025). The Discrepancy Between Perceived and Proven Drug Hypersensitivity in a Well‐Defined Cohort of Patients With Inborn Errors of Immunity. Allergy. https://doi.org/10.1111/all.16570en_US
dc.identifier.issn0105-4538
dc.identifier.issn1398-9995
dc.identifier.urihttps://doi.org/10.1111/all.16570
dc.identifier.urihttps://hdl.handle.net/11436/10806
dc.description.abstractBackground: Inborn errors of immunity (IEI) are genetic disorders characterized by recurrent and/or severe infections, autoimmunity, autoinflammation, allergies, and cancer. Despite frequent drug exposures due to recurrent infections and comorbidities, the prevalence and characteristics of drug hypersensitivity reactions (DHR) in pediatric patients with IEI remain understudied. Methods: This multicenter, cross-sectional study evaluated 264 pediatric patients with IEI along with a control group (CG) comprising 443 age-matched controls using a stepwise diagnostic approach, including the patient-reported Study Questionnaire (Study-Q), the European Network for Drug Allergy Questionnaire (ENDA-Q), and confirmatory diagnostic testing, including skin testing and drug provocation tests (DPT). The demographic, clinical, and allergic profiles of the IEI patients and CG were compared. Results: IEI patients (57.6% male) had a median current age of 10 years, with combined immunodeficiencies being the most common phenotype (53.4%). The number of courses for antibiotic use and hospitalization was more frequent in IEI patients compared to CG (p < 0.001). DHR was more common in IEI patients according to Study-Q (p < 0.001) and ENDA-Q (p = 0.002), although proven DHR as a result of confirmatory testing was comparable with CG (1.1% vs. 0.4%, p = 0.368). Despite the fact that suspected DHR in IEI patients was most frequently associated with beta-lactams (47.6%), with 73.9% presenting with urticaria, proven DHR mainly included reactions to radiocontrast agents (n = 2) and ibuprofen (n = 1). Conclusion: Although drug hypersensitivity is often suspected in patients with IEI, proven cases are rare. Standardized protocols, including DPT in drug allergy centers, are essential to differentiate proven allergies from nonallergic reactions, ensure effective treatment, and avoid unnecessary drug restrictions in this unique population.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDrug hypersensitivityen_US
dc.subjectENDAen_US
dc.subjectInborn errors of immunityen_US
dc.titleThe discrepancy between perceived and proven drug hypersensitivity in a well-defined cohort of patients with inborn errors of immunityen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorArınç, Asena Pınar Sefer
dc.identifier.doi10.1111/all.16570en_US
dc.relation.journalAllergyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster